Year Established :
1990
Total Assets(USD) :
choose not to disclose
Total Number of Staff :
300 to 349
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Production capacity,Large Product Line,Contract Manufacturing
Other Competitive Advantages :
1. High Pressure Catalytic Hydrogenation
2. Cryogenic Reaction (≤-78℃)
3. High Pressure Hydrogenolysis Reaction
4. Heck, Suzuki, Negishi, Sonogashira
5. Aromatic Heterocyclic Synthesis
6. Rearrangement Reaction
7. Chiral Resolution
8. Grignard Reaction
Patents and Copyrights :
Business Type :
Manufacturer
R&D Capacity :
OEM
Annual Turnover(USD) :
choose not to disclose
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Finished Dosage,Custom Manufacturing
Product Range :
APIs, advanced pharmaceutical intermediates and customs manfuacturing products.